Redhill Biopharma Ltd (RDHL) — Cash Flow Quality Index
Redhill Biopharma Ltd (RDHL) has a Cash Flow Quality Index of -13.91x as of June 2023. Operating cash flow of $-10.59 Million is below net income of $761.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Redhill Biopharma Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Redhill Biopharma Ltd Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Redhill Biopharma Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RDHL cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Redhill Biopharma Ltd (2023–2023)
Year-by-year earnings quality comparison for Redhill Biopharma Ltd. For live market cap and the full company financial profile, see Redhill Biopharma Ltd stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.50x | $-35.82 Million | $23.92 Million | — |